Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways

Inflammopharmacology. 2021 Aug;29(4):965-974. doi: 10.1007/s10787-021-00800-3. Epub 2021 Mar 19.

Abstract

Cell signaling is considered a part of a network for communication that regulates basic cellular activities. The ability of cells to communicate correctly to the surrounding environment has an important role in development, tissue repair, and immunity as well as normal tissue homeostasis. Dysregulated activation and crosstalk between many intracellular signaling pathways are implicated in the pathogenesis of rheumatoid arthritis (RA), such as the Janus Kinase/signal transducers and activators of transcription (JAK/STAT), Toll-like receptor/nuclear factor kappa B (TLR/NF-κB), phosphatidylinositide-3Kinase/protein kinase B/mammalian target of rapamycin (PI-3K/AKT/mTOR), the stress activated protein kinase/mitogen-activated protein kinase (SAPK/MAPK), and spleen tyrosine kinase (SYK) pathways. Other interrelated pathways that can be targeted to halt the inflammatory status in the disease are purinergic 2X7 receptor (P2X7R)/nucleotide binding oligomerization domain-like receptor family pyrin domain containing 3 or inflammasome (NLRP-3)/NF-κB and Notch pathways. In this review, we will show the orchestrated modulation in the pathogenesis of RA via the crossregulation between dysregulated signaling pathways which can mediate a sustained loop of activation for these signaling pathways as well as aggrevate the inflammatory condition. Also, this review will highlight many targets that can be useful in the development of more effective therapeutic options.

Keywords: JAK/STAT; P2X7R/NLRP-3; PI-3K/AKT/mTOR; SAPK/MAPK; SYK; TLR/NF-κB.

Publication types

  • Review

MeSH terms

  • Animals
  • Antirheumatic Agents / administration & dosage*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / metabolism*
  • Humans
  • Inflammation Mediators / antagonists & inhibitors
  • Inflammation Mediators / metabolism
  • Janus Kinases / antagonists & inhibitors
  • Janus Kinases / metabolism
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • Receptor Cross-Talk / drug effects
  • Receptor Cross-Talk / physiology
  • Receptors, Notch / antagonists & inhibitors
  • Receptors, Notch / metabolism
  • Receptors, Purinergic P2X7 / metabolism
  • Signal Transduction / drug effects*
  • Signal Transduction / physiology*

Substances

  • Antirheumatic Agents
  • Inflammation Mediators
  • NF-kappa B
  • Receptors, Notch
  • Receptors, Purinergic P2X7
  • Janus Kinases